Literature DB >> 2265893

Is there a cognitive marker in major depression?

E Coello1, A Ardila, M Rosselli.   

Abstract

The purpose of this study was to compare adolescents' response pattern on specific visual tasks during acute and recovered states of depression. Twenty-three inpatient adolescents with unipolar depression were tested before and four weeks after treatment. Twenty control subjects matched in age, sex, handedness, and intelligence were tested at similar intervals. Measures included four visual spatial tasks: the Gestalt Street Completion Test, the Judgment of Line Orientation, the Hooper Visual Organization Test and the Rey-Osterrieth Complex Figure. Overall, the results indicated that depressed adolescents performed significantly more poorly than controls in all four measures during both pre-and posttest conditions. They demonstrated greatest difficulty in measures of Gestalt Closure and Judgment of Line Orientation. However, the Gestalt Closure task was the only one to be correlated to severity of depression. These findings are discussed in the light of previous research suggesting a right hemisphere dysfunction and the existence of a cognitive marker in affective disorders.

Entities:  

Mesh:

Year:  1990        PMID: 2265893     DOI: 10.3109/00207459008987167

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  Gestalt perception and local-global processing in high-functioning autism.

Authors:  Sven Bölte; Martin Holtmann; Fritz Poustka; Armin Scheurich; Lutz Schmidt
Journal:  J Autism Dev Disord       Date:  2006-10-07

2.  Visuospatial and mathematical dysfunction in major depressive disorder and/or panic disorder: A study of parietal functioning.

Authors:  Brady D Nelson; Stewart A Shankman
Journal:  Cogn Emot       Date:  2015-02-24

3.  BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder.

Authors:  J Strauss; C L Barr; C J George; C M Ryan; N King; S Shaikh; M Kovacs; J L Kennedy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.